Cited by 72

RNAi-mediated antiviral immunity in mammals

Berkhout, Ben·2018·Current Opinion in Virology

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.coviro.2018.07.008

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • RNAi technologies (such as siRNA or shRNA) may have an impact on the induction of the cellular anti-viral response, which may confound the interpretation of downstream experimental data.

    “It should also be considered that RNAi technologies (such siRNA or shRNA) may have an impact on the induction of the cellular anti-viral response (Berkhout, 2018), which may confound the interpretation of downstream experimental data.”

    From Guidance document on Good cell and tissue culture practice 2.0 (GCCP 2.0) (2021) · cites this paper as Berkhout, 2018

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 78

  1. Hamilton AJ, Baulcombe DC: A species of small antisense RNA in posttranscriptional gene silencing in plants. Science 1999, 286:950-952.
  2. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC: Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998, 391:806-811.
  3. Papaefthimiou I, Hamilton A, Denti M, Baulcombe D, Tsagris M, Tabler M: Replicating potato spindle tuber viroid RNA is accompanied by short RNA fragments that are characteristic of post-transcriptional gene silencing. Nucleic Acids Res 2001, 29:2395-2400.
  4. Voinnet O, Pinto YM, Baulcombe DC: Suppression of gene silencing: a general strategy used by diverse DNA and RNA viruses of plants. Proc Natl Acad Sci U S A 1999, 96:14147- 14152.
  5. Saleh MC, Tassetto M, van Rij RP, Goic B, Gausson V, Berry B, Jacquier C, Antoniewski C, Andino R: Antiviral immunity in Drosophila requires systemic RNA interference spread. Nature 2009, 458:346-350.
  6. Czech B, Malone CD, Zhou R, Stark A, Schlingeheyde C, Dus M, Perrimon N, Kellis M, Wohlschlegel JA, Sachidanandam R et al.: An endogenous small interfering RNA pathway in Drosophila. Nature 2008, 453:729-731.
  7. Hemmes H, Lakatos L, Goldbach R, Burgyan J, Prins M: The NS3 protein of Rice Hoja blanca tenuivirus suppresses RNA silencing in plant and insect hosts by efficiently binding both siRNAs and miRNAs. RNA 2007, 13:1079-1089.
  8. Wang XH, Aliyari R, Li WX, Li HW, Kim K, Carthew R, Atkinson P, Ding W: RNA interference directs innate immunity against viruses in adult Drosophila. Science 2006, 312:452-454.
  9. van Rij RP, Saleh MC, Berry B, Foo C, Houk A, Antoniewski C, Andino R: The RNA silencing endonuclease Argonaute 2 mediates specific antiviral immunity in Drosophila melanogaster. Genes Dev 2006, 20:2985-2995.
  10. Galiana-Arnoux D, Dostert C, Schneemann A, Hoffmann JA, Imler JL: Essential function in vivo for Dicer-2 in host defense against RNA viruses in drosophila. Nat Immunol 2006, 7:590- 597.
  11. Li H, Li WX, Ding SW: Induction and suppression of RNA silencing by an animal virus. Science 2002, 296:1319-1321.
  12. Ding SW, Voinnet O: Antiviral immunity directed by small RNAs. Cell 2007, 130:413-426.
  13. Parameswaran P, Sklan E, Wilkins C, Burgon T, Samuel MA, Lu R, Ansel KM, Heissmeyer V, Einav S, Jackson W et al.: Six RNA viruses and forty-one hosts: viral small RNAs and modulation of small RNA repertoires in vertebrate and invertebrate systems. PLoS Pathog 2010, 6:e1000764.
  14. Kennedy EM, Whisnant AW, Kornepati AV, Marshall JB, Bogerd HP, Cullen BR: Production of functional small interfering RNAs by an amino-terminal deletion mutant of human Dicer. Proc Natl Acad Sci U S A 2015, 112:E6945-6954.
  15. Weng KF, Hung CT, Hsieh PT, Li ML, Chen GW, Kung YA, Huang PN, Kuo RL, Chen LL, Lin JY et al.: A cytoplasmic RNA virus generates functional viral small RNAs and regulates viral IRES activity in mammalian cells. Nucleic Acids Res 2014, 42:12789-12805.
  16. Pfeffer S, Zavolan M, Grasser FA, Chien M, Russo JJ, Ju J, John B, Enright AJ, Marks D, Sander C et al.: Identification of virus- encoded microRNAs. Science 2004, 304:734-736.
  17. Bennasser Y, Le SY, Benkirane M, Jeang KT: Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity 2005, 22:607-619.
  18. Soifer HS, Zaragoza A, Peyvan M, Behlke MA, Rossi JJ: A potential role for RNA interference in controlling the activity of the human LINE-1 retrotransposon. Nucleic Acids Res 2005, 33:846-856.
  19. Triboulet R, Mari B, Lin YL, Chable-Bessia C, Bennasser Y, Lebrigand K, Cardinaud B, Maurin T, Barbry P, Baillat V et al.: Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science 2007, 315:1579-1582.
  20. Wilkins C, Dishongh R, Moore SC, Whitt MA, Chow M, Machaca K: RNA interference is an antiviral defence mechanism in Caenorhabditis elegans. Nature 2005, 436:1044-1047.
  21. Bogerd HP, Skalsky RL, Kennedy EM, Furuse Y, Whisnant AW, Flores O, Schultz KL, Putnam N, Barrows NJ, Sherry B et al.: Replication of many human viruses is refractory to inhibition by endogenous cellular microRNAs. J Virol 2014, 88:8065-8076.
  22. Haasnoot J, de Vries W, Geutjes EJ, Prins M, de Haan P, Berkhout B: The Ebola virus VP35 protein is a suppressor of RNA silencing. PLoS Pathog 2007, 3:e86.
  23. Chen W, Zhang Z, Chen J, Zhang J, Zhang J, Wu Y, Huang Y, Cai X, Huang A: HCV core protein interacts with Dicer to antagonize RNA silencing. Virus Res 2008, 133:250-258.
  24. Xu N, Segerman B, Zhou X, Akusjarvi G: Adenovirus virus- associated RNAII-derived small RNAs are efficiently incorporated into the RNA-induced silencing complex and associate with polyribosomes. J Virol 2007, 81:10540-10549.
  25. Andersson MG, Haasnoot PCJ, Xu N, Berenjian S, Berkhout B, Akusjarvi G: Suppression of RNA interference by adenovirus virus-associated RNA. J Virol 2005, 79:9556-9565.
  26. Cullen BR: Is RNA interference involved in intrinsic antiviral immunity in mammals? Nat Immunol 2006, 7:563-567.
  27. Berkhout B, Sanders RW: Molecular strategies to design an escape-proof antiviral therapy. Antiviral Res 2011, 92:7-14.
  28. Barichievy S, Saayman S, Arbuthnot P, Weinberg MS: RNA interference-based gene expression strategies aimed at sustained therapeutic inhibition of HIV. Curr Top Med Chem 2009, 9:1065-1078.
  29. Bitko V, Musiyenko A, Shulyayeva O, Barik S: Inhibition of respiratory viruses by nasally administered siRNA. Nat Med 2005, 11:50-55.
  30. Zhou H, Jin M, Yu Z, Xu X, Peng Y, Wu H, Liu J, Liu H, Cao S, Chen H: Effective small interfering RNAs targeting matrix and nucleocapsid protein gene inhibit influenza A virus replication in cells and mice. Antiviral Res 2007, 76:186-193.
  31. Murakami M, Ota T, Nukuzuma S, Takegami T: Inhibitory effect of RNAi on Japanese encephalitis virus replication in vitro and in vivo. Microbiol Immunol 2005, 49:1047-1056.
  32. Lu A, Zhang H, Zhang X, Wang H, Hu Q, Shen L, Schaffhausen BS, Hou W, Li L: Attenuation of SARS coronavirus by a short hairpin RNA expression plasmid targeting RNA-dependent RNA polymerase. Virology 2004, 324:84-89.
  33. Chen W, Yan W, Du Q, Fei L, Liu M, Ni Z, Sheng Z, Zheng Z: RNA interference targeting VP1 inhibits foot-and-mouth disease virus replication in BHK-21 cells and suckling mice. J Virol 2004, 78:6900-6907.
  34. Das AT, Brummelkamp TR, Westerhout EM, Vink M, Madiredjo M, Bernards R, Berkhout B: Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J Virol 2004, 78:2601-2605.
  35. Boden D, Pusch O, Lee F, Tucker L, Ramratnam B: Human immunodeficiency virus type 1 escape from RNA interference. J Virol 2003, 77:11531-11535.
  36. von Eije KJ, Ter Brake O, Berkhout B: Human immunodeficiency virus type 1 escape is restricted when conserved genome sequences are targeted by RNA interference. J Virol 2008, 82:2895-2903.
  37. Ter Brake O, von Eije KJ, Berkhout B: Probing the sequence space available for HIV-1 evolution. AIDS 2008, 22:1875-1877.
  38. Ter Brake O, 't Hooft K, Liu YP, Centlivre M, von Eije KJ, Berkhout B: Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition. Mol Ther 2008, 16:557- 564.
  39. Haasnoot J, Westerhout EM, Berkhout B: RNA interference against viruses: strike and counterstrike. Nat Biotechnol 2007, 25:1435-1443.
  40. Saayman S, Barichievy S, Capovilla A, Morris KV, Arbuthnot P, Weinberg MS: The efficacy of generating three independent anti-HIV-1 siRNAs from a single U6 RNA Pol III-expressed long hairpin RNA. PLoS ONE 2008, 3:e2602.
  41. Werk D, Pinkert S, Heim A, Zeichhardt H, Grunert HP, Poller W, Erdmann VA, Fechner H, Kurreck J: Combination of soluble coxsackievirus-adenovirus receptor and anti-coxsackievirus siRNAs exerts synergistic antiviral activity against coxsackievirus B3. Antiviral Res 2009, 83:298-306.
  42. Martinez MA, Gutierrez A, Armand-Ugon M, Blanco J, Parera M, Gomez J, Clotet B, Este JA: Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication. AIDS 2002, 16:2385-2390.
  43. An DS, Donahue RE, Kamata M, Poon B, Metzger M, Mao SH, Bonifacino A, Krouse AE, Darlix JL, Baltimore D et al.: Stable reduction of CCR5 by RNAi through hematopoietic stem cell transplant in non-human primates. Proc Natl Acad Sci U S A 2007, 104:13110-13115.
  44. Anderson J, Akkina R: HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector. AIDS Res Ther 2005, 2:1.
  45. Butticaz C, Ciuffi A, Munoz M, Thomas J, Bridge A, Pebernard S, Iggo R, Meylan P, Telenti A: Protection from HIV-1 infection of primary CD4 T cells by CCR5 silencing is effective for the full spectrum of CCR5 expression. Antivir Ther 2003, 8:373-377.
  46. Mibayashi M, Martinez-Sobrido L, Loo YM, Cardenas WB, Gale M Jr, Garcia-Sastre A: Inhibition of retinoic acid-inducible gene I- mediated induction of beta interferon by the NS1 protein of influenza A virus. J Virol 2007, 81:514-524.
  47. Guo Z, Chen LM, Zeng H, Gomez JA, Plowden J, Fujita T, Katz JM, Donis RO, Sambhara S: NS1 protein of influenza A virus inhibits the function of intracytoplasmic pathogen sensor, RIG-I. Am J Respir Cell Mol Biol 2007, 36:263-269.
  48. Fernandez-Sesma A, Marukian S, Ebersole BJ, Kaminski D, Park MS, Yuen T, Sealfon SC, Garcia-Sastre A, Moran TM: Influenza virus evades innate and adaptive immunity via the NS1 protein. J Virol 2006, 80:6295-6304.
  49. Min JY, Krug RM: The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2 0 - 5 0 oligo (A) synthetase/RNase L pathway. Proc Natl Acad Sci U S A 2006, 103:7100-7105.
  50. Zhou A, Paranjape J, Brown TL, Nie H, Naik S, Dong B, Chang A, Trapp B, Fairchild R, Colmenares C et al.: Interferon action and apoptosis are defective in mice devoid of 2 0 ,5 0 -oligoadenylate- dependent RNase L. EMBO J 1997, 16:6355-6363.
  51. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ et al.: Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006, 441:101-105.
  52. Marques JT, Devosse T, Wang D, Zamanian-Daryoush M, Serbinowski P, Hartmann R, Fujita T, Behlke MA, Williams BR: A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells. Nat Biotechnol 2006, 24:559-565.
  53. Djuranovic S, Nahvi A, Green R: A parsimonious model for gene regulation by miRNAs. Science 2011, 331:550-553.
  54. Goubau D, Deddouche S, Reis e Sousa C: Cytosolic sensing of viruses. Immunity 2013, 38:855-869.
  55. Maillard PV, Van der Veen AG, Deddouche-Grass S, Rogers NC, Merits A, Reis ESC: Inactivation of the type I interferon pathway reveals long double-stranded RNA-mediated RNA interference in mammalian cells. EMBO J 2016, 35:2505-2518.
  56. Seo GJ, Kincaid RP, Phanaksri T, Burke JM, Pare JM, Cox JE, Hsiang TY, Krug RM, Sullivan CS: Reciprocal inhibition between intracellular antiviral signaling and the RNAi machinery in mammalian cells. Cell Host Microbe 2013, 14:435-445.
  57. Sidahmed A, Abdalla S, Mahmud S, Wilkie B: Antiviral innate immune response of RNA interference. J Infect Dev Ctries 2014, 8:804-810.
  58. Jopling CL, Schu ¨tz S, Sarnow P: Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome. Cell Host Microbe 2008, 4:77-85.
  59. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P: Modulation of hepatitis C virus RNA abundance by a liver- specific microRNA. Science 2005, 309:1577-1581.
  60. Lecellier CH, Dunoyer P, Arar K, Lehmann-Che J, Eyquem S, Himber C, Saib A, Voinnet O: A cellular microRNA mediates antiviral defense in human cells. Science 2005, 308:557-560.
  61. Berkhout B, Jeang KT: RISCy business: microRNAs, pathogenesis, and viruses. J Biol Chem 2007, 282:26641-26645.
  62. Pedersen IM, Cheng G, Wieland S, Volinia S, Croce CM, Chisari FV, David M: Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 2007, 449:919-922.
  63. Li Y, Lu J, Han Y, Fan X, Ding SW: RNA interference functions as an antiviral immunity mechanism in mammals. Science 2013, 342:231-234.
  64. Maillard PV, Ciaudo C, Marchais A, Li Y, Jay F, Ding SW, Voinnet O: Antiviral RNA interference in mammalian cells. Science 2013, 342:235-238.
  65. Sagan SM, Sarnow P: Molecular biology. RNAi, antiviral after all. Science 2013, 342:207-208.
  66. Li Y, Basavappa M, Lu J, Dong S, Cronkite DA, Prior JT, Reinecker HC, Hertzog P, Han Y, Li WX et al.: Induction and suppression of antiviral RNA interference by influenza A virus in mammalian cells. Nat Microbiol 2016, 2:16250.
  67. Qiu Y, Xu Y, Zhang Y, Zhou H, Deng YQ, Li XF, Miao M, Zhang Q, Zhong B, Hu Y et al.: Human virus-derived small RNAs can confer antiviral immunity in mammals. Immunity 2017, 46:992- 1004 e1005. Study on a mutant of the human enterovirus 71 that lacks a functional RNAi suppressor. This led to the abundant production in mice of viral siRNAs that confer antiviral immunity upon loading into Ago to degrade the cognate HEV71 RNA.
  68. Cullen BR, Cherry S, tenOever BR: Is RNA interference a physiologically relevant innate antiviral immune response in mammals? Cell Host Microbe 2013, 14:374-378.
  69. Goic B, Vodovar N, Mondotte JA, Monot C, Frangeul L, Blanc H, Gausson V, Vera-Otarola J, Cristofari G, Saleh MC: RNA- mediated interference and reverse transcription control the persistence of RNA viruses in the insect model Drosophila. Nat Immunol 2013, 14:396-403.
  70. Goic B, Stapleford KA, Frangeul L, Doucet AJ, Gausson V, Blanc H, Schemmel-Jofre N, Cristofari G, Lambrechts L, Vignuzzi M et al.: Virus-derived DNA drives mosquito vector tolerance to arboviral infection. Nat Commun 2016, 7:12410.
  71. Poirier EZ, Goic B, Tome-Poderti L, Frangeul L, Boussier J, Gausson V, Blanc H, Vallet T, Loyd H, Levi LI et al.: Dicer-2- dependent generation of viral DNA from defective genomes of RNA viruses modulates antiviral immunity in Insects. Cell Host Microbe 2018, 23:353-365 e358. Broadening of the antiviral program in insects.
  72. Suzuki Y, Frangeul L, Dickson LB, Blanc H, Verdier Y, Vinh J, Lambrechts L, Saleh MC: Uncovering the repertoire of endogenous flaviviral elements in Aedes mosquito genomes. J Virol 2017, 91:e00571.
  73. Paro S, Imler JL, Meignin C: Sensing viral RNAs by Dicer/RIG-I like ATPases across species. Curr Opin Immunol 2015, 32:106- 113.
  74. Baum A, Sachidanandam R, Garcia-Sastre A: Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing. Proc Natl Acad Sci U S A 2010, 107:16303-16308.
  75. Xu J, Sun Y, Li Y, Ruthel G, Weiss SR, Raj A, Beiting D, Lopez CB: Replication defective viral genomes exploit a cellular pro- survival mechanism to establish paramyxovirus persistence. Nat Commun 2017, 8:799.
  76. Ghildiyal M, Seitz H, Horwich MD, Li C, Du T, Lee S, Xu J, Kittler EL, Zapp ML, Weng Z et al.: Endogenous siRNAs derived from transposons and mRNAs in Drosophila somatic cells. Science 2008, 320:1077-1081.
  77. Schnettler E, de VW, Hemmes H, Haasnoot J, Kormelink R, Goldbach R, Berkhout B: The NS3 protein of rice Hoja blanca virus complements the RNAi suppressor function of HIV-1 Tat. EMBO Rep 2009, 10:258-263. Trans-kingdom activity of the HIV-1 RNA suppressor protein Tat in plants.
  78. Qian S, Zhong X, Yu L, Ding B, de Haan P, Boris-Lawrie K: HIV-1 Tat RNA silencing suppressor activity is conserved across kingdoms and counteracts translational repression of HIV-1. Proc Natl Acad Sci U S A 2009, 106:605-610.

Cited by

Sorted by citations

Authors
Berkhout, B.
Venue
Current Opinion in Virology
Publisher
Elsevier BV
Published
2018-10
Volume
32
Pages
9-14
ISSN
1879-6257
Cited by
72
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review